Viridian Therapeutics Ors Inc (VRDN)
Working Capital Ratio
92.73%
Quarterly · Period ending:
VRDN Working Capital Ratio
Latest reported92.73%period ending
Latest reported92.73%period ending
VRDN Quarterly Working Capital Ratio (18.18% → 92.73%)
Quarterly working capital ratio
High-resolution chart · PNG
VRDN working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 92.7311% | |
| 92.8927% | |
| 91.5633% | |
| 90.3106% | |
| 90.3561% | |
| 94.3312% | |
| 93.0205% | |
| 94.0527% | |
| 93.0402% | |
| 95.2901% | |
| 93.7644% | |
| 91.4329% | |
| 90.3852% | |
| 89.041% | |
| 89.9125% | |
| 93.5451% | |
| 85.248% | |
| 90.0844% | |
| 91.5654% | |
| 92.0418% | |
| 83.4436% | |
| 85.5624% | |
| 90.6152% | |
| 74.3581% | |
| 77.0435% | |
| 76.0051% | |
| 64.6322% | |
| 71.7079% | |
| 79.8081% | |
| 86.1674% | |
| 88.6465% | |
| 90.0278% | |
| 93.9575% | |
| 94.5098% | |
| 91.4064% | |
| 84.72% | |
| 85.3956% | |
| 85.9259% | |
| -7.6544% | |
| 48.5214% | |
| 59.3785% | |
| 66.96% | |
| 71.8183% | |
| 77.6576% | |
| 74.7212% | |
| 76.1796% | |
| 59.2904% | |
| 69.928% | |
| 71.562% | |
| -3.6608% | |
| 18.1823% |